ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies

. 2023 Jun 16;49(7):727–759. doi: 10.1007/s00134-023-07050-7

Recommendation 9.1
We recommend that patients with severe ARDS not due to COVID-19 as defined by the EOLIA trial eligibility criteria, should be treated with ECMO in an ECMO center which meets defined organizational standards, adhering to a management strategy similar to that used in the EOLIA trial. Strong recommendation, moderate level of evidence in favor
This recommendation applies also to patients with severe ARDS due to COVID-19. Strong recommendation; low level of evidence in favor for indirectness.

Recommendation 9.1

We recommend that patients with severe ARDS not due to COVID-19 as defined by the EOLIA trial eligibility criteria, should be treated with ECMO in an ECMO center which meets defined organizational standards, adhering to a management strategy similar to that used in the EOLIA trial.

Strong recommendation, moderate level of evidence in favor

This recommendation applies also to patients with severe ARDS due to COVID-19.

Strong recommendation; low level of evidence in favor for indirectness.